StonvexLoading…
StonvexStonvexStonvexCore line items from LCID's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.35B | $807.83M | $595.27M | $608.18M |
Operating Income | $-3.50B | $-3.02B | $-3.10B | $-2.59B |
Net Income | $-2.70B | $-2.71B | $-2.83B | $-1.30B |
EPS (Diluted) | $-12.09 | $-12.52 | $-13.59 | $-1.51 |
Total Assets | $8.39B | $9.65B | $8.51B | $7.88B |
Total Liabilities | $5.39B | $4.48B | $3.66B | $3.53B |
Cash & Equivalents | $997.83M | $1.61B | $1.37B | $1.74B |
Free Cash Flow OCF − CapEx | $-3.80B | $-2.90B | $-3.40B | $-3.30B |
Shares Outstanding | 327.37M | 303.14M | 2.30B | 1.83B |